NDAINJECTIONINJECTABLEPriority Review
Approved
Jul 1995
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
4
Mechanism of Action
Prostaglandin Receptor Agonists
Pharmacologic Class:
Prostaglandin Analog
Indications (1)
Clinical Trials (4)
Users Study Of The Caverject Delivery System
Started Mar 2013
48 enrolled
Healthy
Caverject User Study
Started Feb 2011
48 enrolled
Erectile Dysfunction
Alprostadil in Maculopathy Study (AIMS)
Started Jul 2006
37 enrolled
Macular Degeneration
Alprostadil in Peripheral Arterial Occlusive Disease (PAOD) Stage IV
Started Mar 2004
840 enrolled
Peripheral Arterial Occlusive Disease